Marshall Islands vs Tonga: Alcohol and drug use disorders deaths by sex
Marshall Islands
0.01 deaths
in 2021
Tonga
0.02 deaths
in 2021
Marshall Islands rank
186th
Tonga rank
184th
Alcohol and drug use disorders deaths by sex over time
- Marshall Islands
- Tonga
How they compare
Tonga currently reports 0.02 deaths against 0.01 deaths in Marshall Islands, a difference of 0.01 deaths.
That makes Tonga's figure about 2.0 times Marshall Islands's.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Marshall Islands ahead.
Marshall Islands ranks 186th and Tonga ranks 184th of 194 countries.
Across the 3 decades both report, Marshall Islands averaged higher in 1 and Tonga in 2.
Head to head by decade
| Decade | Marshall Islands | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.023 deaths | 0.02 deaths | 0.003 deaths | Marshall Islands |
| 2010s | 0.013 deaths | 0.02 deaths | 0.007 deaths | Tonga |
| 2020s | 0.01 deaths | 0.02 deaths | 0.01 deaths | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher alcohol and drug use disorders deaths by sex, Marshall Islands or Tonga?
- Tonga, at 0.02 deaths against 0.01 deaths in Marshall Islands as of 2021.
- What is the difference in alcohol and drug use disorders deaths by sex between Marshall Islands and Tonga?
- 0.01 deaths, with Tonga ahead.
- How many years of comparable data are there for Marshall Islands and Tonga?
- 22 years are reported by both, from 2000 to 2021.
- How do Marshall Islands and Tonga rank globally for alcohol and drug use disorders deaths by sex?
- Marshall Islands ranks 186th and Tonga ranks 184th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Alcohol and drug use disorders deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from substance use disorders in females.